logo
logo
Sign in

Dupuytren's Disease Market Forecast: Growth Opportunities and Challenges

avatar
Steve Anderson
Dupuytren's Disease Market Forecast: Growth Opportunities and Challenges

The global dupuytren’s disease market size is expected to reach USD 5.87 billion by 2030, registering a CAGR of 4.55% from 2023 to 2030, according to a new report by Grand View Research, Inc. Dupuytren’s disease is a debilitating condition characterized by the abnormal thickening and shortening of palm tissue, leading to the formation of claw-like finger deformities. This projected market expansion highlights the growing recognition of the importance of addressing and treating this condition effectively. The industry presents lucrative prospects for stakeholders, such as pharmaceutical companies, medical device manufacturers, and healthcare providers to develop innovative therapies and interventions. As the prevalence of the condition continues to rise, there is an escalating demand for effective treatments that can improve symptoms and enhance patients' quality of life.

Dupuytren’s Disease Market Report Highlights

·        The type II disease segment dominated the market in 2022 due to its higher prevalence, more severe symptoms, and greater demand for treatment options

·        In addition, advancements in medical technology have focused on addressing challenges specific to type II Dupuytren's disease, leading to a wider range of effective treatments available for patients

·        By type, the treatment segment held a dominant revenue share in 2022 due to the increasing demand for effective treatment options to alleviate symptoms and improve the quality of life for individuals

·        The hospitals end-use segment held the largest market share in 2022 due to advanced infrastructure, specialized care, and referral networks

·        Europe established a strong regional position in the market in 2022. This can be attributed to factors, such as advanced healthcare infrastructure, increasing prevalence of the disease, and presence of key players driving innovation and access to treatment options in the region

Gain deeper insights on the market and receive your free copy with TOC now @: Dupuytren's Disease Market Report

Consequently, intensified research and development efforts are anticipated in the near future, leading to advancements in treatment options and potential breakthroughs in managing Dupuytren's disease. In a recent study, adalimumab emerged as a potentially cost-effective treatment choice during the early stages of Dupuytren’s disease. The research findings suggest that this medication holds promise in effectively managing the condition while providing value for the investment. These results underscore the potential advantages of adalimumab as a practical and economically viable treatment option specifically for individuals in the early stages of Dupuytren’s disease. The growing awareness and understanding of the disease among healthcare professionals and patients, along with advancements in medical research and diagnostics, are driving the market expansion.

Improved detection rates and timely intervention have increased the demand for effective treatments. Endo Pharmaceuticals’ “Watching Education Unfold” campaign, featuring real patients, aims to raise awareness about Dupuytren’s contracture and educate the public and healthcare community about the condition and available treatment options. This initiative is expected to contribute to heightened awareness, early diagnosis, and improved management of contractures. In addition, significant advancements in medical technology and therapeutic approaches, such as injectable collagenase and minimally invasive surgical techniques, have played a crucial role in driving the market forward. Injectable collagenase treatment like Xiaflex has gained approval for Dupuytren's contracture in multiple countries, offering a less invasive alternative to traditional surgical procedures and leading to improved patient outcomes and shorter recovery times. These advancements in medical technology and therapeutics are significant contributors to the overall growth of the market.

For More Details or Sample Copy please visit link @: https://www.grandviewresearch.com/industry-analysis/dupuytrens-disease-market-report/request/rs1

List of Key Players in Dupuytrens Disease Market

·        Bayer AG

·        Novartis AG

·        Pfizer Inc

·        Nantong Jinghua Pharmaceutical Co, Ltd.

·        Actiza Pharmaceutical Pvt. Ltd.

·        Endo International plc

·        Bristol-Meyers Squibb Company

·        Spear Pharmaceuticals

·        GSK plc

·        AstraZeneca

·        Hikma Pharmaceuticals PLC

·        LEO Pharma A/S

·        Fresenius Kabi AG

Research Methodology

We employ a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecasts possible. We utilize a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our market estimates and forecasts are derived through simulation models. A unique model is created and customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously.

For Customized reports or Special Pricing please visit @: https://www.grandviewresearch.com/checkout/select-license/dupuytrens-disease-market-report

Segmented dupuytren’s disease market report based on disease type, type, end-use, and region

Table of Contents

Chapter 1. Methodology and Scope

          1.1. Market Segmentation

            1.1.1. Market Definitions

          1.2. Objectives

            1.2.1. Objective - 1

            1.2.2. Objective - 2

            1.2.3. Objective - 3

          1.3. Research Methodology

          1.4. Information Procurement

            1.4.1. Purchased Database

            1.4.2. Gvr’s Internal Database

            1.4.3. Secondary Sources

            1.4.4. Primary Research

          1.5. Information Or Data Analysis

            1.5.1. Data Analysis Models

          1.6. Market Formulation & Validation

          1.7. Model Details

            1.7.1. Commodity Flow Analysis

          1.8. List of Secondary Sources

          1.9. List of Abbreviations

          1.10. List of Primary Sources

Chapter 2. Executive Summary

          2.1. Market Snapshot

          2.2. Disease Type and Type Snapshot

          2.3. End-use Snapshot

          2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

          3.1. Market Segmentation and Scope

          3.2. Market Lineage Outlook

            3.2.1. Parent Market Outlook

            3.2.2. Related/Ancillary Market Outlook

          3.3. Market Trends and Outlook

          3.4. Market Dynamics

            3.4.1. Increasing Prevalence

            3.4.2. Rising Awareness and Diagnosis Rates

            3.4.3. High Adoption in Treatment

          3.5. Market Restraint Analysis

            3.5.1. Limited Curative Treatment Options

            3.5.2. High Treatment Cost

          3.6. Business Environment Analysis

            3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)

            3.6.2. Porter’s Five Forces Analysis

          3.7. COVID-19 Impact Analysis

Chapter 4. Disease Type Business Analysis

          4.1. Dupuytren’s Disease Market: Disease Type Movement Analysis

          4.2. Type I

            4.2.1. Type I Market, 2018 - 2030 (USD Million)

          4.3. Type II

            4.3.1. Type II Market, 2018 - 2030 (USD Million)

          4.4. Type III

            4.4.1. Type III Market, 2018 - 2030 (USD Million)

Chapter 5. Type Business Analysis

          5.1. Dupuytren’s Disease Market: Disease Type Movement Analysis

          5.2. Diagnosis

            5.2.1. Diagnosis Market, 2018 - 2030 (USD Million)

            5.2.2. Physical Examination

              5.2.2.1. Physical Examination Market, 2018 - 2030 (USD Million)

            5.2.3. X-ray

              5.2.3.1. X-ray Market, 2018 - 2030 (USD Million)

          5.3. Treatment

            5.3.1. Treatment Market, 2018 - 2030 (USD Million)

            5.3.2. Surgery

              5.3.2.1. Surgery Market, 2018 - 2030 (USD Million)

            5.3.3. Radiation Therapy

              5.3.3.1. Radiation Therapy Market, 2018 - 2030 (USD Million)

            5.3.4. Needle Aponeurotomy

              5.3.4.1. Needle Aponeurotomy Market, 2018 - 2030 (USD Million)

            5.3.5. Steroid Short

              5.3.5.1. Steroid Short Market, 2018 - 2030 (USD Million)

            5.3.6. Enzyme Injection

              5.3.6.1. Enzyme Injection Market, 2018 - 2030 (USD Million)

            5.3.7. Occupational Therapy

              5.3.7.1. Occupational Therapy Market, 2018 - 2030 (USD Million)

            5.3.8. Others

              5.3.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

          6.1. Dupuytren’s Disease Market Segmentation: End-Use Movement Analysis

          6.2. Hospitals

            6.2.1. Hospitals Market, 2018 - 2030 (USD Million)

          6.3. Clinics

            6.3.1. Clinics Market, 2018 - 2030 (USD Million)

          6.4. Academic & Research Institutes

            6.4.1. Academic And Research Institutes Market, 2018 - 2030 (USD Million)

          6.5. Others

            6.5.1. Others Market, 2018 - 2030 (USD Million)


collect
0
avatar
Steve Anderson
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more